Equity Overview
Price & Market Data
Price: $1.54
Daily Change: -$0.02 / 1.30%
Range: $1.54 - $1.56
Market Cap: $993,592,064
Volume: 3,230
Company Details
Employees: 229
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.